The landscape for oligonucleotides is diverse. As the pipeline for oligonucleotide therapeutics such as antisense, siRNA, and gRNA continues to expand, it grows along with increasing demand for primers and probes for clinical diagnostics.
Modifications, conjugation, and novel formulations are increasing the complexity of oligonucleotide therapeutics, necessitating analytical tools that deliver high-quality results, improve efficiency, and enable regulatory compliance. Waters brings industry-leading expertise, providing analytical solutions to support the development and commercialization of these exciting new molecules. With Waters, your lab can: